Case Study: a clinical-stage pharmaceutical company achieves 6X faster clinico-genomic data integration and analysis with Elucidata’s Polly

A clinical-stage pharmaceutical company accelerates clinico-genomic data integration 6X with Elucidata

A clinical-stage pharmaceutical company faced challenges in integrating and analyzing diverse clinico-genomic datasets, which was a slow and costly process. They partnered with Elucidata to leverage its Polly platform to address these data interoperability hurdles.

Elucidata's solution used Polly to automate data transformation, standardization, and harmonization. This resulted in the customer achieving a 6x faster creation of data products and a 4x reduction in associated costs, leading to an estimated $5 million in annual savings. The streamlined data integration also accelerated new product development by 25%, significantly improving time-to-market for their innovations.